The uncontrolled release of drugs in conventional drug delivery systems has led to the
introduction of new nanotechnology-based drug delivery systems and the use of targeted …

The selective and efficient drug delivery to tumor cells can remarkably improve different
cancer therapeutic approaches. There are several nanoparticles (NPs) which can act as a …

Folate receptor (FR) is highly expressed in many types of human cancers, and it has been
actively studied for developing targeted chemotherapy and diagnostic agents. Tremendous …

The development of specialized nanoparticles for use in the detection and treatment of
cancer is increasing. Methods are being proposed and tested that could target treatments …

Cancer theranostics represents a strategy that aims at combining diagnosis with therapy
through the simultaneous imaging and targeted delivery of therapeutics to cancer cells …

In normal tissues, the expression of folate receptors is low and limited to cells that are
important for embryonic development or for folate reabsorption. However, in several …

Targeted drug therapy or “smart” drug delivery, potentially combined with simultaneous
imaging modalities to monitor the delivery of drugs to specific tissues, is arguably the “holy …

Folate-conjugated chitosan nanoparticles represent a promising nanoplatform for targeted
delivery of anticancer drugs. The nanoparticle carrier can protect the therapeutic agents from …

Conventional chemotherapeutic approaches in cancer therapy such as surgery,
chemotherapy, and radiotherapy have several disadvantages due to their nontargeted …

Breast cancer is one of the most prevalent types of cancer among female patients, which is
caused by mutations in the oestrogen/progesterone receptors. Conventional treatment …